[A new drug approach approved in the USA. Cox-2 inhibitor in intestinal cancer].
D011125:Adenomatous Polyposis Coli / Q000235:genetics / Q000517:prevention & control*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D011720:Pyrazoles; D013449:Sulfonamides / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014481:United States
D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib